Pegfilgrastim biosimilar (Shandong New Time)

培非格司亭生物类似药(鲁南制药集团)

Report date: 2026/05/20 20:02:01

Base Information

Drug NamePegfilgrastim biosimilar (Shandong New Time)
Drug Alias Name非格司亭生物仿制药(鲁南制药集团)培非司亭生物仿制药(鲁南制药集团)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusN/A
Highest Status in ChinaN/A
Originator CompaniesLunan Pharmaceutical Group Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeL03AA13
Related LinksN/A